• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

IGF2BP1,一种癌症中RNA周转的保守调节因子。

IGF2BP1, a Conserved Regulator of RNA Turnover in Cancer.

作者信息

Glaß Markus, Misiak Danny, Bley Nadine, Müller Simon, Hagemann Sven, Busch Bianca, Rausch Alexander, Hüttelmaier Stefan

机构信息

Institute of Molecular Medicine, Martin Luther University Halle-Wittenberg, Halle, Germany.

出版信息

Front Mol Biosci. 2021 Mar 22;8:632219. doi: 10.3389/fmolb.2021.632219. eCollection 2021.

DOI:10.3389/fmolb.2021.632219
PMID:33829040
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8019740/
Abstract

The oncofetal IGF2 mRNA-binding protein 1 (IGF2BP1) promotes tumor progression in a variety of solid tumors and its expression is associated with adverse prognosis. The main role proposed for IGF2BP1 in cancer cells is the stabilization of mRNAs encoding pro-oncogenic factors. Several IGF2BP1-RNA association studies, however, revealed a plethora of putative IGF2BP1-RNA targets. Thus, at present the main conserved target RNAs and pathways controlled by IGF2BP1 in cancer remain elusive. In this study, we present a set of genes and cancer hallmark pathways showing a conserved pattern of deregulation in dependence of IGF2BP1 expression in cancer cell lines. By the integrative analysis of these findings with publicly available cancer transcriptome and IGF2BP1-RNA association data, we compiled a set of prime candidate target mRNAs. These analyses confirm a pivotal role of IGF2BP1 in controlling cancer cell cycle progression and reveal novel cancer hallmark pathways influenced by IGF2BP1. For three novel target mRNAs identified by these studies, namely AURKA, HDLBP and YWHAZ, we confirm IGF2BP1 mRNA stabilization. In sum our findings confirm and expand previous findings on the pivotal role of IGF2BP1 in promoting oncogenic gene expression by stabilizing target mRNAs in a mainly 3'UTR, mA-, miRNA-, and potentially AU-rich element dependent manner.

摘要

癌胚胰岛素样生长因子2信使核糖核酸结合蛋白1(IGF2BP1)在多种实体瘤中促进肿瘤进展,其表达与不良预后相关。IGF2BP1在癌细胞中的主要作用是稳定编码促癌因子的信使核糖核酸。然而,多项IGF2BP1与核糖核酸关联研究揭示了大量可能的IGF2BP1核糖核酸靶点。因此,目前IGF2BP1在癌症中控制的主要保守靶点核糖核酸和途径仍不清楚。在本研究中,我们展示了一组基因和癌症标志性途径,它们在癌细胞系中呈现出依赖IGF2BP1表达的保守失调模式。通过将这些发现与公开的癌症转录组和IGF2BP1核糖核酸关联数据进行综合分析,我们编制了一组主要候选靶信使核糖核酸。这些分析证实了IGF2BP1在控制癌细胞周期进程中的关键作用,并揭示了受IGF2BP1影响的新的癌症标志性途径。对于这些研究确定的三个新靶信使核糖核酸,即极光激酶A(AURKA)、高密度脂蛋白结合蛋白(HDLBP)和14-3-3ζ(YWHAZ),我们证实了IGF2BP1对信使核糖核酸的稳定作用。总之,我们的研究结果证实并扩展了先前关于IGF2BP1通过以主要依赖3'非翻译区、N6-甲基腺苷、微小核糖核酸以及潜在富含AU元件的方式稳定靶信使核糖核酸来促进致癌基因表达的关键作用的发现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe38/8019740/4ffd8e305ede/fmolb-08-632219-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe38/8019740/4ffd8e305ede/fmolb-08-632219-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe38/8019740/4ffd8e305ede/fmolb-08-632219-g002.jpg

相似文献

1
IGF2BP1, a Conserved Regulator of RNA Turnover in Cancer.IGF2BP1,一种癌症中RNA周转的保守调节因子。
Front Mol Biosci. 2021 Mar 22;8:632219. doi: 10.3389/fmolb.2021.632219. eCollection 2021.
2
The oncofetal RNA-binding protein IGF2BP1 is a druggable, post-transcriptional super-enhancer of E2F-driven gene expression in cancer.癌胚 RNA 结合蛋白 IGF2BP1 是一种可药物治疗的、转录后 E2F 驱动的基因表达的超级增强子,在癌症中。
Nucleic Acids Res. 2020 Sep 4;48(15):8576-8590. doi: 10.1093/nar/gkaa653.
3
IGF2BP1 enhances an aggressive tumor cell phenotype by impairing miRNA-directed downregulation of oncogenic factors.IGF2BP1 通过损害 miRNA 对致癌因子的下调作用增强了侵袭性肿瘤细胞表型。
Nucleic Acids Res. 2018 Jul 6;46(12):6285-6303. doi: 10.1093/nar/gky229.
4
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner.IGF2BP1 通过 m6A 和 miRNA 依赖性方式促进癌症中 SRF 依赖性转录。
Nucleic Acids Res. 2019 Jan 10;47(1):375-390. doi: 10.1093/nar/gky1012.
5
IGF2BP1 promotes cell migration by regulating MK5 and PTEN signaling.IGF2BP1 通过调节 MK5 和 PTEN 信号促进细胞迁移。
Genes Dev. 2012 Jan 15;26(2):176-89. doi: 10.1101/gad.177642.111.
6
IGF2BP1-An Oncofetal RNA-Binding Protein Fuels Tumor Virus Propagation.IGF2BP1—一种癌胚 RNA 结合蛋白,促进肿瘤病毒的增殖。
Viruses. 2023 Jun 24;15(7):1431. doi: 10.3390/v15071431.
7
IGF2BP1: a post-transcriptional "driver" of tumor cell migration.IGF2BP1:肿瘤细胞迁移的转录后“驱动因素”。
Cell Adh Migr. 2012 Jul-Aug;6(4):312-8. doi: 10.4161/cam.20628. Epub 2012 Jul 1.
8
ETV6/RUNX1 transcript is a target of RNA-binding protein IGF2BP1 in t(12;21)(p13;q22)-positive acute lymphoblastic leukemia.在t(12;21)(p13;q22)阳性急性淋巴细胞白血病中,ETV6/RUNX1转录本是RNA结合蛋白IGF2BP1的一个靶点。
Blood Cells Mol Dis. 2016 Mar;57:30-4. doi: 10.1016/j.bcmd.2015.11.006. Epub 2015 Nov 15.
9
Integrative Analyses of mRNA Expression Profile Reveal the Involvement of in Chicken Adipogenesis.mRNA 表达谱的综合分析揭示了 在鸡脂肪生成中的作用。
Int J Mol Sci. 2019 Jun 14;20(12):2923. doi: 10.3390/ijms20122923.
10
The oncogenic triangle of HMGA2, LIN28B and IGF2BP1 antagonizes tumor-suppressive actions of the let-7 family.HMGA2、LIN28B和IGF2BP1的致癌三角拮抗let-7家族的肿瘤抑制作用。
Nucleic Acids Res. 2016 May 5;44(8):3845-64. doi: 10.1093/nar/gkw099. Epub 2016 Feb 24.

引用本文的文献

1
The METTL3/IGF2BP1 axis-mediated m6 A modification of TRIM11 mRNA suppresses ferroptosis and accelerates malignant progression in non-small cell lung cancer cells by degrading ACSL4.METTL3/IGF2BP1轴介导的TRIM11 mRNA的m6A修饰通过降解ACSL4抑制非小细胞肺癌细胞中的铁死亡并加速恶性进展。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Jul 16. doi: 10.1007/s00210-025-04207-7.
2
AVJ16 inhibits lung carcinoma by targeting IGF2BP1.AVJ16通过靶向IGF2BP1抑制肺癌。
Oncogene. 2025 Jul 8. doi: 10.1038/s41388-025-03449-2.
3
Long Non-Coding RNAs and RNA-Binding Proteins in Pancreatic Cancer Development and Progression.

本文引用的文献

1
Promising Therapy in Lung Cancer: Spotlight on Aurora Kinases.肺癌的潜在疗法:聚焦极光激酶
Cancers (Basel). 2020 Nov 14;12(11):3371. doi: 10.3390/cancers12113371.
2
IGF2BP1 is a targetable SRC/MAPK-dependent driver of invasive growth in ovarian cancer.IGF2BP1 是卵巢癌中 SRC/MAPK 依赖性浸润性生长的可靶向驱动因子。
RNA Biol. 2021 Mar;18(3):391-403. doi: 10.1080/15476286.2020.1812894. Epub 2020 Sep 2.
3
MiR-93 suppresses tumorigenesis and enhances chemosensitivity of breast cancer via dual targeting E2F1 and CCND1.
长链非编码RNA与RNA结合蛋白在胰腺癌发生发展中的作用
Cancers (Basel). 2025 May 8;17(10):1601. doi: 10.3390/cancers17101601.
4
HaloPROTAC3 treatment activates the unfolded protein response of the endoplasmic reticulum in nonengineered mammalian cell lines.HaloPROTAC3处理可激活非工程化哺乳动物细胞系中内质网的未折叠蛋白反应。
Mol Biol Cell. 2025 May 1;36(5):mr3. doi: 10.1091/mbc.E24-08-0342. Epub 2025 Mar 19.
5
The IGF2BP1 oncogene is a druggable mA-dependent enhancer of YAP1-driven gene expression in ovarian cancer.IGF2BP1癌基因是卵巢癌中YAP1驱动基因表达的一种可靶向的依赖于m⁶A的增强子。
NAR Cancer. 2025 Feb 24;7(1):zcaf006. doi: 10.1093/narcan/zcaf006. eCollection 2025 Mar.
6
Stress granules: Guardians of cellular health and triggers of disease.应激颗粒:细胞健康的守护者与疾病的触发因素
Neural Regen Res. 2026 Feb 1;21(2):588-597. doi: 10.4103/NRR.NRR-D-24-01196. Epub 2025 Feb 24.
7
IGF2BP1 phosphorylation in the disordered linkers regulates ribonucleoprotein condensate formation and RNA metabolism.IGF2BP1 磷酸化在无序连接区调节核糖核蛋白凝聚物的形成和 RNA 代谢。
Nat Commun. 2024 Oct 20;15(1):9054. doi: 10.1038/s41467-024-53400-4.
8
Association of insulin-like growth factor II mrna-binding protein 3 (IMP3) expression with prognostic and morphological factors in endometrial cancer.胰岛素样生长因子 II mRNA 结合蛋白 3(IMP3)表达与子宫内膜癌预后和形态因素的关系。
Rev Bras Ginecol Obstet. 2024 Jul 26;46. doi: 10.61622/rbgo/2024rbgo61. eCollection 2024.
9
Survival-Related Genes on Chromosomes 6 and 17 in Medulloblastoma.染色体 6 和 17 上与生存相关的神经母细胞瘤基因。
Int J Mol Sci. 2024 Jul 9;25(14):7506. doi: 10.3390/ijms25147506.
10
A RBM47 and IGF2BP1 mediated circular FNDC3B-FNDC3B mRNA imbalance is involved in the malignant processes of osteosarcoma.RBM47和IGF2BP1介导的环状FNDC3B-FNDC3B mRNA失衡参与骨肉瘤的恶性进展。
Cancer Cell Int. 2023 Dec 21;23(1):334. doi: 10.1186/s12935-023-03175-3.
miR-93 通过双重靶向 E2F1 和 CCND1 抑制乳腺癌的肿瘤发生和增强化疗敏感性。
Cell Death Dis. 2020 Aug 14;11(8):618. doi: 10.1038/s41419-020-02855-6.
4
The oncofetal RNA-binding protein IGF2BP1 is a druggable, post-transcriptional super-enhancer of E2F-driven gene expression in cancer.癌胚 RNA 结合蛋白 IGF2BP1 是一种可药物治疗的、转录后 E2F 驱动的基因表达的超级增强子,在癌症中。
Nucleic Acids Res. 2020 Sep 4;48(15):8576-8590. doi: 10.1093/nar/gkaa653.
5
A large-scale binding and functional map of human RNA-binding proteins.人类 RNA 结合蛋白的大规模结合和功能图谱。
Nature. 2020 Jul;583(7818):711-719. doi: 10.1038/s41586-020-2077-3. Epub 2020 Jul 29.
6
Kinesin family member 11 is a potential therapeutic target and is suppressed by microRNA-30a in breast cancer.驱动蛋白家族成员 11 是一个潜在的治疗靶点,在乳腺癌中受 microRNA-30a 的抑制。
Mol Carcinog. 2020 Aug;59(8):908-922. doi: 10.1002/mc.23203. Epub 2020 Apr 29.
7
An oncopeptide regulates mA recognition by the mA reader IGF2BP1 and tumorigenesis.一种癌肽调节 mA 识别由 mA 阅读器 IGF2BP1 和肿瘤发生。
Nat Commun. 2020 Apr 3;11(1):1685. doi: 10.1038/s41467-020-15403-9.
8
miR-27b-3p suppresses cell proliferation, migration and invasion by targeting LIMK1 in colorectal cancer.miR-27b-3p通过靶向LIMK1抑制结直肠癌中的细胞增殖、迁移和侵袭。
Int J Clin Exp Pathol. 2017 Sep 1;10(9):9251-9261. eCollection 2017.
9
Functions of N6-methyladenosine and its role in cancer.N6-甲基腺苷的功能及其在癌症中的作用。
Mol Cancer. 2019 Dec 4;18(1):176. doi: 10.1186/s12943-019-1109-9.
10
14-3-3 Proteins Are on the Crossroads of Cancer, Aging, and Age-Related Neurodegenerative Disease.14-3-3 蛋白处于癌症、衰老和与年龄相关的神经退行性疾病的十字路口。
Int J Mol Sci. 2019 Jul 18;20(14):3518. doi: 10.3390/ijms20143518.